imatinib mesylate
100 mg/1 · Tablet
By Qilu Pharmaceutical Co., Ltd.
- NDC
- 67184-0532
- Route
- Oral
- Therapeutic class
- Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor
- Marketing category
- ANDA
Package sizes
- 30 BLISTER PACK in 1 CARTON (67184-0532-3) / 10 TABLET in 1 BLISTER PACKNDC 67184-0532-3Available to order
- 90 TABLET in 1 BOTTLE (67184-0532-1)NDC 67184-0532-1Available to order
- 500 TABLET in 1 BOTTLE (67184-0532-2)NDC 67184-0532-2Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.
Related in Oncology & Specialty
See all →Verzenio (abemaciclib)
50 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)
200 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)
100 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)
150 mg/1 · Tablet
Eli Lilly and Company
Available to source
